Synonyms: KPL-716 | KPL716
Compound class:
Antibody
Comment: Vixarelimab (KPL-716) is an anti-oncostatin M (OSM) receptor β subunit monoclonal antibody [1]. It disrupts both interleukin-31 and OSM signalling at the interface between immune cells and connective tissue/stromal cells, by attenuating the MCP-1 response to OSM. The effects of vixarelimab are distinct to those of an anti-IL-31 receptor α monoclonal.
|
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
11350 | vixarelimab |
Synonyms ![]() |
KPL-716 | KPL716 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 1063 |
Other databases | |
GtoPdb PubChem SID | 500839861 |
Search PubMed clinical trials | vixarelimab |
Search PubMed titles | vixarelimab |
Search PubMed titles/abstracts | vixarelimab |